Biomet Says DoJ Scales Down Antitrust Probe
According to the company, the DOJ’s antitrust investigation was prompted by an unsolicited e-mail that Biomet received from a competitor.
The e-mail, which proposed a unified pricing strategy for one hospital, was received by an independent Biomet distributor. However, it was never transmitted to Biomet, the company said, and neither Biomet nor...
To view the full article, register now.